Medifast, Inc. (MED)

163.79
9.92 5.71
NYSE
Prev Close 173.71
Open 173.01
Day Low/High 162.35 / 173.01
52 Wk Low/High 49.03 / 184.29
Volume 142.29K
Exchange NYSE
Shares Outstanding 11.77B
Market Cap 2.03B
P/E Ratio 27.13
Div & Yield N.A. (N.A)
This Dividend Stock Is Good for Both Waistline and Bottom Line

This Dividend Stock Is Good for Both Waistline and Bottom Line

As obesity rates climb higher, the quarterly dividend of Medifast should, too.

Medifast Can Help With Your Diet - But Maybe Not Your Portfolio

Medifast Can Help With Your Diet - But Maybe Not Your Portfolio

Analysis and trading strategy on MED stock.

This Dividend Stock Is Tipping the Scales for Investors

This Dividend Stock Is Tipping the Scales for Investors

As more Americans struggle with obesity, Medifast sees strength in weight-loss offerings.

5 Holiday Stock Ideas for Investors: Cook, Exercise and Sleep

5 Holiday Stock Ideas for Investors: Cook, Exercise and Sleep

Celebrate Thanksgiving with these specially selected picks for your portfolio.

The Week Ahead: Earnings Season Is Far From Over

The Week Ahead: Earnings Season Is Far From Over

Disney, Qualcomm and Square are among 75 key reports we are watching.

Post Holdings Plans to Shake Up the Market With a Spinoff

Post Holdings Plans to Shake Up the Market With a Spinoff

Post's IPO of its star Active Nutrition segment is expected to take place in the December quarter.

Beach Season Spurring Sales Says Medifast CEO

Beach Season Spurring Sales Says Medifast CEO

Shares of Medifast are in robust shape, up nine percent so far this year, heading into the weight loss provider's second busiest season of the year.

Oprah Adding Heft to Resolution Season Says Medifast CEO

Oprah Adding Heft to Resolution Season Says Medifast CEO

New Year’s resolution season is the busiest time of the year in the weight loss industry.

4 Stocks That Are Fit for Fitness

4 Stocks That Are Fit for Fitness

These companies should feast as more obese Americans turn to exercise and healthy foods.

Second Half Looks Strong Despite Higher Ad Spending Says Medifast CEO

Second Half Looks Strong Despite Higher Ad Spending Says Medifast CEO

Medifast finished the first quarter ahead of where it wanted to be and the weight loss company is now gearing up for a strong second half, says CEO Michael MacDonald.

The Trend Is Still Healthy

The Trend Is Still Healthy

Especially true after the weakness in overseas markets.

The Week Ahead: Some Welcome Surprises

The Week Ahead: Some Welcome Surprises

Economic data seem to be shifting for the better.

Medifast Off to Fast Start Despite Nu Skin, Herbalife Hoopla

Medifast Off to Fast Start Despite Nu Skin, Herbalife Hoopla

The start of diet season - January through April - looks bright for Medifast so far, says the company's CEO Michael MacDonald, as does Medifast's expansion plans into Canada.

Medifast Weighs In on Weight Loss War

Medifast Weighs In on Weight Loss War

Weight loss stocks have seen turmoil this summer, but Medifast CEO Michael MacDonald says his company will overcome the problems plaguing Herbalife and Weight Watchers.

Medifast CEO: Meal Replacement = Big Growth

Medifast CEO: Meal Replacement = Big Growth

Medifast CEO Mike MacDonald expects 19% growth in the meal replacement business.

Not Sold on the Uptrend

Not Sold on the Uptrend

After last Friday's follow-through, the action has been unconvincing.

The Week Ahead: Earnings Schmearnings

The Week Ahead: Earnings Schmearnings

While these reports should offer clarity, the election will clear a much bigger overhang on the market.

Weight Loss Pills Not a Threat, Says Medifast CEO

Weight Loss Pills Not a Threat, Says Medifast CEO

Mike MacDonald, CEO of Medifast, says the company's new franchise strategy is propelling its stock and recently approved weight loss pills are not a threat.

A Supplemental Strategy

A Supplemental Strategy

Plenty of activity in the nutritional-supplements industry today.

A Stirring Performance From These Small-Caps

A Stirring Performance From These Small-Caps

These under-the-radar stocks have done very well of late, and they have the fundamentals to back it up.